510(k) K060968
K060968 is an FDA 510(k) premarket notification submitted by Wortham Laboratories, Inc. for the device "STASIS - I, II AND III; SERATHAN - A, B; INTRIN - EA, SI CALCIUM CHLORIDE 0.02M; FIBRINOGEN CONTROL-NORMAL, LOW". The FDA issued a decision of Substantially Equivalent on May 15, 2007. The device falls under product code GIZ (Plasma, Control, Normal), a Class II device regulated under 21 CFR 864.5425.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 15, 2007
- Date Received
- April 7, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Plasma, Control, Normal
- Device Class
- Class II
- Regulation Number
- 864.5425
- Review Panel
- HE
- Submission Type